Bronchopulmonary Dysplasia

Kendig's Disorders of the Respiratory Tract in Children

Volumn , Issue , 2006, Pages 342-358

  Abman, Steven H ^a,b   Davis, Jonathan M ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35948936610     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-3695-5.50023-7     Document Type: Chapter

References (120)

1. Northway WH, Rosan RC, Porter DY Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 1967, 276:357-368.
2. Bland RD, Coalson JJ Chronic lung disease in early infancy 2000, Marcel Dekker, New York.
3. Jobe AH, Bancalari E Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
4. Bancalari E, Abdenour GE, Feller R, Gannon J Bronchopulmonary dysplasia. Clinical presentation. J Pediatr 1979, 95:819-823.
5. Jobe AH The new BPD: An arrest of lung development. Pediatr Res 1999, 46:641-643.
6. Charafeddine L, D'Angio CT, Phelps DL Atypical chronic lung disease patterns in neonates. Pediatrics 1999, 103:759-760.
7. Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of chronic lung disease. J Pediatr 1995, 126:605-610.
8. Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants. Prediction from oxygen requirement in the neonatal period. Pediatrics 1988, 82:527-532.
9. Ellsbury DL, Acarregui MJ, McGuinness GA, et al. Controversy surrounding the use of home oxygen for premature infants with BPD. J Perinatol 2004, 24:36-40.
10. Walsh MC, Wilson-Costello D, Zadell A, et al. Safety, reliability and validity of a physiologic definition of BPD. J Perinatol 2003, 23:451-456.
11. Shepard F, Gray J, Stahlman MT Occurrence of pulmonary fibrosis in children who had idiopathic RDS. J Pediatr 1964, 65:1078.
12. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987, 79:26-30.
13. Hussain AN, Siddiqui NH, Stocker JT Pathology of arrested acinar development in postsurfactant BPD. Hum Pathol 1998, 29:710-717.
14. Bancalari E, Gonzalez A Clinical course and lung function abnormalities during development of chronic lung disease. Chronic Lung Disease in Early Infancy 2000, Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
15. Coalson JJ Pathology of chronic lung disease of early infancy. Chronic Lung Disease in Early Infancy 2000, 85-124. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
16. Panitch HB, Allen JL, Alpert BF, Schidlow DV Effects of CPAP on lung mechanics in infants with acquired tracheomalacia. Am J Respir Crit Care Med 1994, 150:1341-1346.
17. Panitch HB, Keklikian EN, Motely RA, Schidlow DV Effects of altering smooth muscle tone on expiratory flows in patients with tracheomalacia. Pediatr Pulmonol 1990, 9:170-176.
18. O'Brodovich H, Forrest JB, Newhouse MT Ciliary defects associated with the development of BPD. Am Rev Respir Dis 1984, 129:190-193.
19. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997, 177:825-830.
20. Hitti J, Krohn MA, Patton DL, et al. Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol 1997, 177:50-56.
21. Watterberg KL, Demers LM, Scott SM, Murphy S Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996, 97:210-215.
22. Ghezzi F, Gomez R, Romero R, et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998, 78:5-10.
23. Jobe AH Antenatal factors in the development of BPD. Semin Neonatol 2003, 8:9-17.
24. Jobe AH, Newnham JP, Willet KE, et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol 2000, 18:401-408.
25. Crowley PA Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995, 173:322-335.
26. Polk DH, Ikegami M, Jobe AH, et al. Preterm lung function after retreatment with antenatal betamethasone in preterm lambs. Am J Obstet Gynecol 1997, 176:308-315.
27. Banks BA, Cnaan A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999, 181:709-717.
28. 2-rich environment. The antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984, 18:240-244.
29. Ogihara T, Okamoto R, Kim HS, et al. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996, 39:117-119.
30. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993, 74:2234-2241.
31. White CW, Avraham KB, Shanley PF, Groner Y Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991, 87:2162-2168.
32. Wispe JR, Warner BB, Clark JC, et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992, 267:23937-23941.
33. Ahmed MN, Suliman HR, Folz RJ, et al. Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. Am J Respir Crit Care Med 2003, 167:400-405.
34. Dreyfuss DD, Saumon G Ventilator induced lung injury Lessons from experimental studies. Am J Respir Crit Care Med 1998, 157:294-323.
35. Hodson WA Ventilation strategies and BPD. Chronic Lung Disease in Early Infancy 2000, 173-208. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
36. Nilsson R, Grossman G, Robertson B Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res 1978, 12:249-255.
37. Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997, 99:944-952.
38. Carlton DP, Cummings JJ, Scheerer RG, et al. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 1990, 69:577-583.
39. Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the ARDS. N Engl J Med 2000, 342:1301-1308.
40. Bjorklund LJ, Ingimarsson J, Curstedt T, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lungs. Pediatr Res 1997, 42:348-355.
41. Bernstein G, Mannino FL, Heldt GP, et al. Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates. J Pediatr 1996, 128:453-463.
42. Clark RH, Gerstmann DR, Null DM, deLemos RA Prospective, randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992, 89:5-12.
43. Keszler M, Modanlou HD, Brudno DS, et al. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 1997, 100:593-599.
44. Collins MP, Lorenz JM, Jetton JR, Paneth N Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 2001, 50:712-719.
45. Mariani G, Cifuentes J, Carlo WA Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999, 104:1082-1088.
46. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000, 105:1194-1201.
47. Groneck P, Gotz-Speer B, Opperman M, et al. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia. A sequential analysis of inflammatory mediators in respiratory fluids of high-risk neonates. Pediatrics 1994, 93:712-718.
48. Pierce MR, Bancalari E The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995, 19:371-378.
49. Groneck P, Speer CP Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995, 73:F1-F3.
50. Ozdemir A, Brown MA, Morgan WJ Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997, 23:292-306.
51. Jones CA, Cayabyab RG, Kwong KY, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease. A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996, 39:966-975.
52. Ramsay PL, O'Brian SE, Hegemier S, Welty SE Early clinical markers for the development of bronchopulmonary dysplasia. Soluble E-Selectin and ICAM-1. Pediatrics 1998, 102:927-932.
53. Munshi UK, Niu JO, Siddiq MM, Parton LA Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997, 24:331-336.
54. Bland RD, Albertine KH, Carlton DP, et al. Chronic lung injury in preterm lambs. Abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 2000, 48:64-74.
55. Alnahhas MH, Karathanasis P, Kriss VM, et al. Elevated laminin concentrations in lung secretions of preterm infants supported by mechanical ventilation are correlated with radiographic abnormalities. J Pediatr 1997, 131:555-560.
56. 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983, 72:656-666.
57. Stiskal JA, Dunn MS, Shennan AT, et al. Alpha-1-proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity. A randomized, controlled trial. Pediatrics 1998, 101:89-94.
58. Watterberg KL, Scott SM, Backstrom C, et al. Links between early adrenal function and respiratory outcome in preterm infants. Airway inflammation and patent ductus arteriosus. Pediatrics 2000, 105:320-324.
59. Watterberg KL, Gerdes JS, Gifford KL, Lin HM Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999, 104:1258-1263.
60. Wang EE, Ohlsson A, Kellner JD Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity. Results of a metaanalysis. J Pediatr 1995, 127:640-644.
61. Frank L, Groseclose E Oxygen toxicity in newborn rats. The adverse effects of undernutrition. J Appl Physiol 1982, 53:1248-1255.
62. Shenai JP Vitamin A supplementation in very low birth weight neonates. Rationale and evidence. Pediatrics 1999, 104:1369-1374.
63. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999, 340:1962-1968.
64. Nickerson BG, Taussig LM Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics 1980, 65:1140-1144.
65. Bertrand JM, Riley SP, Popkin J, Coates AL The long-term pulmonary sequelae of prematurity. Rhe role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 1985, 312:742-745.
66. Clark DA, Pincus LG, Oliphant M, et al. HLA-A2 and chronic lung disease in neonates. JAMA 1982, 248:1868-1869.
67. Hagan R, Minutillo C, French N, et al. Neonatal chronic lung disease, oxygen dependency and a family history of asthma. Pediatr Pulmonol 1995, 20:277-283.
68. Hallman M, Haatja R Genetic influences and neonatal lung disease. Semin Neonatol 2003, 8:19-27.
69. Kumar VH, Ryan RM Growth factors in the fetal and neonatal lung. Front Biosci 2004, 9:464-480.
70. Bhatt AJ, Pryhuber GS, Huyck H, et al. Disrupted pulmonary vasculature and decreased VEGF, flt-1, and Tie 2 in human infants dying with BPD. Am J Respir Crit Care Med 2000, 164:1971-1980.
71. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000, 279:L600-L607.
72. Abman SH BPD. A vascular hypothesis. Am J Respir Crit Care Med 2001, 164:1755-1756.
73. Goldman SL, Gerhardt T, Sonni R, et al. Early prediction of chronic lung disease by pulmonary function testing. J Pediatr 1983, 102:613-617.
74. Tepper RS, Morgan WJ, Cota K, Taussig LM Expiratory flow limitation in infants with bronchopulmonary dysplasia. J Pediatr 1986, 109:1040-1046.
75. Wolfson MR, Bhutani BK, Shaffer TH, Bowen FW Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984, 104:752.
76. Slavin JD, Mathews J, Spencer RP Pulmonary ventilation/perfusion and reverse mismatches in an infant. Acta Radiol Diagn 1986, 27:708-709.
77. Hakulinen AL, Järvenpaa AL, Turpeinan M, Sorijavi A Diffusing capacity of the lung in school-age children born very preterm with and without BPD. Pediatr Pulmonol 1996, 21:353-360.
78. Abman SH Pulmonary hypertension in chronic lung disease of infancy. Pathogenesis, pathophysiology and treatment. Chronic Lung Disease in Infancy 2000, 619-668. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
79. Parker TA, Abman SH The pulmonary circulation in BPD. Semin Neonatol 2003, 8:51-62.
80. Tomashefski JF, Opperman HC, Vawter GF BPD: A morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984, 2:469-487.
81. Halliday HL, Dumpit FM, Brady JP Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in BPD. Pediatrics 1980, 65:536-540.
82. Abman SH, Wolfe RR, Accurso FJ, et al. Pulmonary vascular response to oxygen in infants with severe BPD. Pediatrics 1985, 75:80-84.
83. Walther FJ, Bender FJ, Leighton JO Persistent pulmonary hypertension in premature neonates with severe RDS. Pediatrics 1992, 90:899-904.
84. Fouron JC, LeGuennec JC, Villemont D, et al. Value of echocardiography in assessing the outcome of BPD. Pediatrics 1980, 65:529-535.
85. Goodman G, Perkin R, Anas N Pulmonary hypertension in infants with BPD. J Pediatr 1988, 112:67-72.
86. Mourani PM, Ivy DD, Gao D, Abman SH Pulmonary vascular effects of inhaled NO and oxygen tension in BPD. Am J Respir Crit Care Med 2004, 170:1006-1013.
87. Apkon M, Nehgme RA, Lister G Cardiovascular abnormalities in BPD. Chronic Lung Disease in Infancy 2000, 321-356. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
88. Abman SH, Warady BA, Lum GM, Koops BL Systemic hypertension in infants with BPD. J Pediatr 1984, 104:928-931.
89. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone treatment in extremely low birth weight infants. N Engl J Med 2001, 344:95-101.
90. Murphy BP, Inder TE, Huppi PS, et al. Impaired cerebral cortical gray matter after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001, 107:217-221.
91. Abman SH, Accurso FJ, Koops BL Experience with home oxygen in the management of infants with BPD. Clin Pediatr 1984, 23:471-476.
92. Groothius JR, Rosenberg AA Home oxygen promotes weight gain in infants with BPD. Am J Dis Childhood 1987, 141:992-995.
93. Abman SH Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child 2002, 87:F15-F18.
94. Subcommittee of the Assembly of Pediatrics, American Thoracic Society Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003, 168:356-396.
95. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP) A randomized controlled trial. Pediatrics 2000, 105:295-310.
96. Hazinski TA Drug therapy for established BPD. Chronic Lung Disease in Infancy 2000, 257-284. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
97. Rush MG, Englehardt B, Parker RA, et al. Double blind, placebo controlled trial of alternate day furosemide therapy in infants with chronic BPD. J Pediatr 1990, 117:112-118.
98. De Boeck K, Smith J, Van Lierde S, Devlieger H Response to bron-chodilators in clinically stable 1 year old patients with BPD. J Pediatr 1998, 157:75-79.
99. Yoder MC, Chua R, Tepper R Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with BPD. Am Rev Respir Dis 1991, 143:1044-1048.
100. Halliday HL Clinical trials of postnatal corticosteroids. Inhaled and systemic. Biol Neonate 1999, 76(1):29-40.
101. Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in premature infants. Pediatrics 2002, 109:330-338.
102. Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent BPD. N Engl J Med 1999, 340:1005-1010.
103. Tepper RS, Morgan WJ, Cota K, Taussig LM Expiratory flow limitation in infants with BPD. J Pediatr 1986, 109:1040-1046.
104. Gerhardt T, Hehre D, Feller R, et al. Serial determinations of pulmonary function in infants with CLD. J Pediatr 1987, 110:448-456.
105. Baraldi E, Filippone M, Trevisanuto D, et al. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997, 155:149-155.
106. Jacob SV, Coates AL, Lands LC, et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr 1998, 133:193-200.
107. Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD Effect of preterm birth on pulmonary function at school age. A prospective controlled study. J Pediatr 1998, 133:188-192.
108. Mitchell SH, Teague G Reduced gas transfer at rest and during exercise in school age survivors of BPD. Am J Respir Crit Care Med 1998, 157:1406-1412.
109. Filipone M, Sartor M, Zacchello F, Baraldi E Flow limitation in infants with BPD and respiratory function at school age. Lancet 2003, 361:753-754.
110. Northway WH, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of BPD. N Engl J Med 1990, 323:1793-1799.
111. Higgins RD, Richter SE, Davis JM Nasal continuous positive airway pressure facilitates extubation of very low birth weight neonates. Pediatrics 1991, 88:999-1003.
112. Davis JM, Richter SE, Kendig JW, Notter RH High frequency jet ventilation and surfactant treatment of newborns with severe respiratory failure. Pediatr Pulmonol 1992, 13:108-112.
113. Yeh TF, Lin YJ, Lin H, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004, 350:1304-1313.
114. Jobe AH Postnatal corticosteroids for preterm infants-do what we say, not what we do. N Engl J Med 2004, 350:1349-1351.
115. Davis JM, Parad RB, Michele T, et al. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant CuZn superoxide dismutase. Pediatrics 2003, 111:469-476.
116. Kinsella JP, Walsh WF, Bose C, et al. Randomized controlled trial of inhaled nitric oxide in premature neonates with severe hypoxemic respiratory failure. Lancet 1999, 354:1061-1065.
117. Banks BA, Seri I, Ischiropoulos H, et al. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999, 103:610-618.
118. Kinsella JP, Parker TA, Galan H, et al. Effects of inhaled NO on pulmonary edema and lung neutrophil accumulation in severe experimental HMD. Pediatr Res 1997, 41:457-463.
119. Tang JR, Markham NE, Lin YJ, et al. Inhaled NO attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004, 287:L344-L351.
120. Schreiber MD, Gin-Mestan K, Marks JD, et al. Inhaled NO in premature infants with respiratory distress syndrome. N Engl J Med 2003, 349:2099-2107.